

[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI

[ Sun, Oct 30th 2022
] - WOPRAI
Paul Matteis Maintained (VRTX) at Hold and Held Target at $289 on, Oct 30th, 2022
Paul Matteis of Stifel, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $289 on, Oct 30th, 2022.
Paul has made no other calls on VRTX in the last 4 months.
There are 12 other peers that have a rating on VRTX. Out of the 12 peers that are also analyzing VRTX, 4 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $288 on, Friday, October 28th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $285 on, Friday, October 28th, 2022
- Do Kim of "Piper Sandler" Maintained at Hold with Increased Target to $288 on, Wednesday, August 17th, 2022
- Brian Skorney of "Baird" Maintained at Hold and Held Target at $250 on, Friday, August 5th, 2022
These are the ratings of the 8 analyists that currently disagree with Paul
- Michael Yee of "Jefferies" Maintained at Strong Buy and Held Target at $340 on, Friday, October 28th, 2022
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $335 on, Friday, October 28th, 2022
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $313 on, Friday, October 28th, 2022
- Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $330 on, Friday, October 28th, 2022
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $327 on, Monday, October 24th, 2022
- Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $337 on, Friday, October 21st, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Friday, August 5th, 2022
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $365 on, Wednesday, July 13th, 2022
Contributing Sources